NIMs fell in 3Q20 on subdued interest rates
Banks’ NIMs dropped 4bps QoQ to 1.53% on low interest rates in 3Q20. Current 3M-SIBOR/3M-SOR of 0.40%/0.18% are at QTD averages (Figure 2). We expect NIMs to stay at this level in 4Q20, which would work out to a full-year average of 1.60%.
Turnover volume for SGX’s newly-launched FTSE Taiwan Index Futures was 1.9mn in November, just 3% shy of volumes for its MSCI substitute a year ago. Successful product replacements ahead of MSCI contract expiries in February 2021 give us reason to believe that SGX’s earnings will not be materially affected in FY21.
Earnings fell by varying degrees but a few trends could be observed.
NII: NII was down 11-13% YoY amid weak interest rates. We expect similar quarterly run rates in FY21 as loan growth remains weak.
Fee and commission income: While fees and commissions were down 2-9% YoY, they grew 14-17% QoQ. This tracked Singapore’s exit from its circuit breaker in the third quarter. Other non-interest income was higher for DBS and OCBC on the back of better trading income. A slower recovery in non-interest income is expected in FY21 as economic conditions remain challenging in the short term.
Allowances: Allowances stayed high as banks continued to build reserves for potential NPL formation in FY21. This was in preparation for the end of Singapore’s loan moratoriums next year. All three banks remained ahead of schedule in their reserve build-up, accumulating 31-52% of expected credit costs by 3Q20 (Figure 9).
Following Phase 1 expiry of loan moratoriums in Malaysia in October, interest payments for most of OCBC’s and UOB’s loans have resumed in Malaysia. Loans under moratorium fell to 5% from 9% of OCBC’s loan book and from 16% to 10% of UOB’s. Loans under moratorium for DBS remained at around 5% as it has no loan exposure to Malaysia.
Better clarity on asset quality allowed UOB to lower its credit-cost outlook to 30-40bps from 50-60bps for FY21. OCBC expects credit costs to come in at the lower end of its 100-130bp guidance for FY20 and FY21. DBS maintains its 80-130bp range for the two years.
Reserve Bank of India (RBI) approved merger of DBS and Lakshmi Vilas Bank (LVB)
On 25 November, the RBI approved the merger of DBS India and LVB (Non-Rated). DBS will inject Rs2,500 crore or about S$476mn into the merged entity. Alongside operating losses from LVB, we are expecting short-term merger expenses.
This could present a short-term drag to DBS’ earnings recovery in FY21.
Two digital full banking (DFB) and two digital wholesale banking (DWB) licences
On 4 December, the MAS announced the results of digital-banking licence bids. Four were awarded, two DFB and two DWB. This was one less than the total five – two DFB and three DWB – that MAS was willing to issue. The successful DWBs were deemed to be demonstrably stronger across the selection criteria. MAS may grant more DWB licences in the future.
Winners of the two DFB licences were the Grab-Singtel (ST SP, Neutral, TP: S$2.44) consortium and SEA Group. Winners of the two DWB licenses were a wholly-owned entity of Ant Group and a consortium comprising Greenland Financial Holdings, Linklogis Hong Kong, and Beijing Co-operative Equity Investment Fund Management.
All digital banks are expected to begin operations in 2022. Till then, we do not foresee any material impact on the three banks’ earnings. We believe the three have a head start in the digitalisation race. We also expect the digital entrants to face a challenging operating environment in a well-banked society.
Investment actions
Maintain Neutral. While the credit outlook has improved for banks, we believe that an earnings recovery to pre-COVID-19 levels will only be further down the road, in FY22.
We downgrade OCBC and UOB to NEUTRAL from ACCUMULATE as low interest rates, coupled with higher credit costs, continue to contribute to weak earnings. This is despite our higher revised TPs (Figure 10) to factor in normalising allowances in FY21. We remain NEUTRAL on DBS as a downgrade was made in August on an earlier rally.
For sector exposure, we prefer UOB (UOB SP, Neutral, S$21.10) as lower credit costs guided by the bank should lift pressure off its earnings faster than for its peers.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
